Global & Public Health (all articles)
CDC panel moves health workers, nursing home residents to front of COVID vaccine line
2 Dec, 2020 | 07:26h | UTCCDC panel moves health workers, nursing home residents to front of COVID vaccine line – CIDRAP
Two meta-analysis find ethnic minorities disproportionately affected by coronavirus
2 Dec, 2020 | 07:22h | UTCMeta-analysis 1: Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths: A Systematic Review – Annals of Internal Medicine
Meta-analysis 2: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis – EClinicalMedicine
Commentary: Ethnic minorities disproportionately affected by coronavirus, meta-study finds – Reuters
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019. At least one in every three people in the world needs rehabilitation at some point in the course of their illness or injury
2 Dec, 2020 | 07:17h | UTC
Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
2 Dec, 2020 | 07:19h | UTC
Commentary on Twitter
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review https://t.co/lmWQNgpIfd Existing evidence supports the wide-held belief that the the risk of #SARSCoV2 transmission is lower outdoors (< 10%).
— Carlos del Rio (@CarlosdelRio7) December 1, 2020
WHO World malaria report 2020: 20 years of global progress & challenges
1 Dec, 2020 | 08:27h | UTCWorld malaria report 2020: 20 years of global progress & challenges – World Health Organization
News Release: WHO calls for reinvigorated action to fight malaria
Moderna released more Covid-19 vaccine results. They’re very encouraging.
1 Dec, 2020 | 08:15h | UTCModerna released more Covid-19 vaccine results. They’re very encouraging. – Vox
Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP
Commentary on Twitter
Moderna has announced the final results of the 30,000-person efficacy trial for its #COVID19 vaccine candidate, reporting that the vaccine had 100% efficacy against severe disease. https://t.co/Cgg0I5nv9r
— News from Science (@NewsfromScience) November 30, 2020
Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data
1 Dec, 2020 | 08:13h | UTC
Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial
1 Dec, 2020 | 08:08h | UTCCommentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters
Critically ill patients with COVID-19: A narrative review on prone position
1 Dec, 2020 | 08:07h | UTCCritically Ill Patients with COVID-19: A Narrative Review on Prone Position – Pulmonary Therapy
The Ioannidis affair: A tale of major scientific overreaction
1 Dec, 2020 | 08:10h | UTCThe Ioannidis Affair: A Tale of Major Scientific Overreaction – Scientific American
The COVID science wars: Shutting down scientific debate is hurting the public health
1 Dec, 2020 | 08:11h | UTCThe COVID Science Wars – Scientific American
Report: SARS-CoV-2 setting-specific transmission rates. Households showed the highest transmission rates (21.1%). Asymptomatic infections do occur but much less efficiently than symptomatic infection.
30 Nov, 2020 | 01:01h | UTCFull report: SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis – Imperial College London
AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose
1 Dec, 2020 | 08:05h | UTC
No evidence for increased transmissibility from mutations in SARS-CoV-2
30 Nov, 2020 | 01:06h | UTCCommentaries: Mutations not making coronavirus able to spread more rapidly -study – Reuters AND Covid-19 has NOT become more infectious: Study identifies almost 13,000 coronavirus mutations but none – including the dominant D614G strain – made it better at spreading – Daily Mail
Study: Fewer than 10% of people in the US had detectable SARS-CoV-2 antibodies as of September 2020
30 Nov, 2020 | 01:00h | UTCEstimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – JAMA Internal Medicine
Commentaries: Less than 10% of Americans had COVID by September, study finds – CIDRAP AND Antibodies, Immunity, and COVID-19 – JAMA Internal Medicine AND Covid-19: Nationwide SARS-CoV-2 Seroprevalence Remains Low – Physician’s Weekly
Commentary on Twitter
.@CDCgov tested more than 177,000 serum samples across 52 sites (50 states, DC, and Puerto Rico) between July 27 and September 24 for #SARSCoV2 antibodies. The study found that, in 45 US sites, less than 10% of samples had evidence of previous infection https://t.co/U4hp68fFAx
— JAMA Internal Medicine (@JAMAInternalMed) November 24, 2020
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany estimated at 0.36%
30 Nov, 2020 | 01:02h | UTCInfection fatality rate of SARS-CoV2 in a super-spreading event in Germany – Nature Communications
Seroprevalence meta-analysis predicts 643 million already infected by SARS-CoV-2 globally
30 Nov, 2020 | 00:59h | UTCOriginal study: Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis – medRxiv
Opinion – Covid-19: controversial trial may actually show that masks protect the wearer
30 Nov, 2020 | 00:58h | UTCCovid-19: controversial trial may actually show that masks protect the wearer – The BMJ Opinion
Original study and commentaries: Randomized trial suggesting mask use does not protect the wearer from Covid-19 sparks controversy
Related commentary on Twitter (thread – click for more)
1/
My appraisal of the Danish mask study (DANMASK-19): This was a negative trial – masks were not shown to prevent #COVID19.Could chance or bias make this outcome more likely?
Does this mean we don’t need to wear masks?Let’s take a deeper look.#HowIReadThisPaper
(Thread) pic.twitter.com/bAUuajgtaI
— Rahul Ganatra (@rbganatra) November 28, 2020
Editor’s Choice: The curious case of the Danish mask study
30 Nov, 2020 | 00:56h | UTCEditor’s Choice: The curious case of the Danish mask study – The BMJ
Original study and commentaries: Randomized trial suggesting mask use does not protect the wearer from Covid-19 sparks controversy
Randomized trial: Intravenous iron is superior to oral iron for the treatment of anemia in women after childbirth in a low-income setting
27 Nov, 2020 | 08:41h | UTC
Commentary on Twitter
In a randomised trial in Tanzania, intravenous ferric carboxymaltose proved safe and better than oral iron at achieving haemoglobin normalisation (>115 g/L) at 6 weeks after childbirth in women with iron deficiency anaemia https://t.co/F5sau45dwL pic.twitter.com/qqa8cGbMqZ
— The Lancet Global Health (@LancetGH) November 25, 2020
New WHO guidelines on physical activity and sedentary behavior – Every move counts towards better health
27 Nov, 2020 | 08:45h | UTCWHO guidelines on physical activity and sedentary behaviour – World Health Organization
News release: Every move counts towards better health – says WHO
Commentaries: Aim to exceed weekly recommended physical activity level to offset health harms of prolonged sitting – BMJ AND You only need 30 to 40 minutes of exercise per day to ‘offset’ sitting at your desk all day, new analysis finds – Business Insider AND Physical activity guidelines 2020: comprehensive and inclusive recommendations to activate populations – The Lancet
Commentary on Twitter
Launched today new 2020 WHO Guidelines on PA & Sedentary behaviour. Check out WHO website for summary in 6 UN languages. Take home message #EveryMoveCounts #BeActive Thanks to everyone who helped to produce this new global policy @WHO @ISPAH @BJSM_BMJ pic.twitter.com/tersZkMj3i
— fiona bull (@fiona_bull) November 25, 2020
Study ranks the most effective non-pharmaceutical interventions for reducing COVID-19 spread
27 Nov, 2020 | 08:36h | UTCRanking the effectiveness of worldwide COVID-19 government interventions – Nature Human Behaviour
Commentary: Epidemiology: Assessing non-pharmaceutical interventions in reducing COVID-19 spread – Nature Asia
Long Covid: Comprehensive health assessment three months after recovery from acute COVID-19 revealed problems in several health domains in a substantial number of patients
27 Nov, 2020 | 08:33h | UTC
Covid-19: 15% of people responsible for 80% of secondary infections
27 Nov, 2020 | 08:27h | UTCTransmission heterogeneities, kinetics, and controllability of SARS-CoV-2 – Science
Commentary: What we can learn from contact tracing an entire province – Ars Technica
Commentary on Twitter
Study of 1,178 #COVID19 cases & their 15,648 contacts in Hunan, China. Just 15% of people were responsible for 80% of secondary infections.
Children were less likely to be infected than young to middle-aged adults, but infectiousness didn’t differ by age.https://t.co/PYaj9pbSJo pic.twitter.com/mREh5wWkKd
— Dr Zoë Hyde (@DrZoeHyde) November 26, 2020
Perspective: “With global push for COVID-19 vaccines, China aims to win friends and cut deals”
27 Nov, 2020 | 08:26h | UTCWith global push for COVID-19 vaccines, China aims to win friends and cut deals – Science